Michigan clinic warns against rat poison in homes with dogs

Bayshore Veterinary Hospital is using a local spike in poisonings to deliver a broader safety message: don’t use rat poison in a house with a dog if you can avoid it. In a June 29, 2026 story from WLUC/Upper Michigan’s Source, the Harvey, Michigan, practice said it had treated six dogs for rodenticide exposure over the prior two weeks. Dr. Tim Hunt told the station that dogs are attracted to the bait’s smell and taste, and that clinical signs can emerge within one to three days, depending on the product involved. (uppermichiganssource.com)

The warning lands in a rodenticide market that has changed significantly over the past decade. EPA restrictions pushed consumer products toward ready-to-use bait stations and away from loose pellets and second-generation anticoagulants for residential sale. But those changes didn’t eliminate risk. EPA says retail rodenticides can still contain active ingredients such as bromethalin and cholecalciferol, and emphasizes that misuse can still harm pets. Merck’s veterinary toxicology overview adds that even “pet-resistant” stations may be breached by determined animals. (epa.gov)

That context helps explain why a seemingly familiar “rat poison” story still matters clinically. Hunt recommended conventional traps or other non-poison approaches for households with dogs, and said that if exposure occurs, it’s important to know exactly which product was used. That advice aligns with toxicology guidance from Merck, ASPCA, and Pet Poison Helpline, all of which stress that brand name, bait color, or formulation alone may not reliably identify the toxicant. Accurate identification is central because the mechanism, onset, and treatment differ by class. (uppermichiganssource.com)

The biggest practical issue for clinics is that newer consumer exposures are increasingly tied to non-anticoagulant products. Merck reports a downward trend in anticoagulant rodenticide exposures and an upward trend in bromethalin exposures from 2009 through 2025, with cholecalciferol also remaining a key concern. Bromethalin is a neurotoxin with no specific antidote, while cholecalciferol can cause severe hypercalcemia and mineralization. By contrast, anticoagulant toxicosis may be more familiar to clinicians because vitamin K1 can be used when indicated. ASPCA and ASPCApro materials also warn that pets can still access bait marketed as resistant or safer, and that waiting for signs is risky, especially with bromethalin. (merckvetmanual.com)

There doesn’t appear to be a formal regulatory action, recall, or manufacturer announcement tied to the Bayshore cases. Instead, this is a local clinical cluster that underscores a national pattern: rodenticide risk hasn’t disappeared, it has shifted. EPA’s current consumer-market framework is designed to reduce accidental exposures, but not every product in circulation is new, some legacy products may still be around homes and outbuildings, and online availability can complicate the picture. Merck specifically notes that older products may not comply with current standards, and that some professional-use products remain readily available through channels that can unintentionally reach consumers. (epa.gov)

Why it matters: For veterinary professionals, this is as much a communication story as a toxicology one. Primary care teams are often the first call when a pet parent finds a chewed bait station or notices vague signs after a suspected exposure. The Bayshore cases are a reminder to standardize intake questions around product name, EPA registration details if available, estimated dose, timing, and whether the pet may also have ingested a poisoned rodent. They also reinforce the value of quick referral pathways to emergency care and poison-control consultation when the active ingredient is unknown or likely non-anticoagulant. (uppermichiganssource.com)

The industry reaction here is less about public debate and more about consistent expert messaging. EPA, ASPCA, Merck, and Pet Poison Helpline all converge on the same point: consumer safeguards reduce risk, but they don’t make rodenticides safe in a home with curious pets. That consistency gives practices a strong foundation for client education, especially in regions where rodent pressure rises seasonally and pet parents may assume newer products are low risk. (epa.gov)

What to watch: Watch for more clinic-led education on non-poison rodent control, more emphasis on bringing the bait package or a photo of the label to the hospital, and continued toxicology attention on bromethalin and cholecalciferol as exposure patterns evolve. (merckvetmanual.com)